Drug: CIPRO Injury: Neuropathy peripheral Quarter: 2016Q3
Total Records: 260 Number of Pages: 13
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
127198601 | CIPRO | Neuropathy peripheral | JANSSEN | 54.88 YR | F | 0 | 20160907 | US |
127198631 | CIPRO | Neuropathy peripheral | JANSSEN | 41.48 YR | M | 98 KG | 20160907 | US |
127198721 | CIPRO | Neuropathy peripheral | JANSSEN | 51.90 YR | F | 0 | 20160907 | US |
127198731 | CIPRO | Neuropathy peripheral | JANSSEN | 0.00 | F | 0 | 20160907 | US |
127199171 | CIPRO | Neuropathy peripheral | JANSSEN | 49.06 YR | M | 132 KG | 20160907 | US |
127199191 | CIPRO | Neuropathy peripheral | JANSSEN | 0.00 | M | 0 | 20160907 | US |
127199321 | CIPRO | Neuropathy peripheral | JANSSEN | 0.00 | M | 0 | 20160907 | US |
127199531 | CIPRO | Neuropathy peripheral | JANSSEN | 62.92 YR | F | 0 | 20160907 | US |
127212861 | CIPRO | Neuropathy peripheral | JANSSEN | 36.48 YR | M | 0 | 20160907 | US |
127256151 | CIPRO | Neuropathy peripheral | FDA-CTU | 61.00 YR | F | 100 KG | 20160906 | US |
127375051 | CIPRO | Neuropathy peripheral | BAYER | 0.00 | 0 | 20160913 | US | |
127436721 | CIPRO | Neuropathy peripheral | BAYER | 0.00 | F | 0 | 20160914 | US |
127548121 | CIPRO | Neuropathy peripheral | JANSSEN | 0.00 | 0 | 20160915 | US | |
127592112 | CIPRO | Neuropathy peripheral | JANSSEN | 0.00 | 0 | 20160922 | US | |
127592121 | CIPRO | Neuropathy peripheral | JANSSEN | 0.00 | 0 | 20160919 | US | |
127621211 | CIPRO | Neuropathy peripheral | JANSSEN | 0.00 | 0 | 20160920 | US | |
127629511 | CIPRO | Neuropathy peripheral | JANSSEN | 0.00 | 0 | 20160920 | US | |
127629521 | CIPRO | Neuropathy peripheral | JANSSEN | 0.00 | 0 | 20160920 | US | |
127760951 | CIPRO | Neuropathy peripheral | BAYER | 0.00 | F | 0 | 20160923 | US |
686700112 | CIPRO | Neuropathy peripheral | BAYER | 40.00 YR | F | 63 KG | 20160815 | US |
Total Records: 260 Number of Pages: 13